Skip to content

APM in the Evoke SCS System to Program Patients With Chronic Pain of the Trunk and/or Limbs

A Prospective, Multicenter, Single-arm Study Examining the Assisted Programming Module (APM) in the Evoke Spinal Cord Stimulation (SCS) System to Program Patients With Chronic Pain of the Trunk and/or Limbs

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06057480
Acronym
APM
Enrollment
30
Registered
2023-09-28
Start date
2023-09-26
Completion date
2024-12-19
Last updated
2025-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Pain, Chronic

Brief summary

Study to evaluate the use of the Assisted Programming Module (APM) in the Evoke Spinal Cord Stimulation (SCS) System to program patients with chronic pain of the trunk and/or limbs.

Interventions

DEVICEAPM

Investigational programming software module, the Assisted Programming Module (APM)

Sponsors

Saluda Medical Pty Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject has or is planning to undergo a temporary trial with Evoke System within the FDA approved indication. * Subject is willing and capable of giving informed consent and able to comply with study-related requirements.

Exclusion criteria

* There are no

Design outcomes

Primary

MeasureTime frameDescription
Change in Evoked Compound Action Potentials (ECAPs) measured in µV by the Evoke SCS Systemend of trial period; 1 month and 3 months post-implantChange in Evoked Compound Action Potentials (ECAPs) measured in µV by the Evoke SCS System
Change in programming parameters (e.g., stimulation frequency [Hz], pulse width [µs], amplitude [mA]) measured by the Evoke SCS Systemend of trial period; 1 month and 3 months post-implantChange in programming parameters (e.g., stimulation frequency \[Hz\], pulse width \[µs\], amplitude \[mA\]) measured by the Evoke SCS System

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026